跳至主要内容
临床试验/NCT00388050
NCT00388050已完成不适用

Wiser Choices for Patients With Type II Diabetes: Diabetes Medication Choice

Mayo Clinic1 个研究点 分布在 1 个国家目标入组 85 人开始时间: 2006年7月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
发起方
Mayo Clinic
入组人数
85
试验地点
1
主要终点
Understanding

研究概览

简要总结

The purpose of this study is to examine how different ways of sharing information about diabetes medication treatment options with patients can affect their choices and health.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Investigator)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Have a diagnosis of type 2 diabetes mellitus of any duration; c-peptide test not required
  • •Use 1 or 2 oral hypoglycemic agents; not using insulin therapy
  • •Are not pregnant
  • •Have stable but inadequate glycemic control: both A1C at the time of eligibility and previous A1c within 6 months between 7-9.5%
  • •Recognize their primary care provider as their main diabetes care provider
  • •Do not have major barriers (i.e., severe hearing impairment, dementia, cannot communicate in English) to participate in shared decision-making (per provider?s assessment)
  • •Have no plans to relocate out of town in the next 6 months
  • •Enrolment is open to males and females of diverse racial backgrounds

排除标准

  • 未提供

研究组 & 干预措施

Diabetes Medication Choice decision aid

Experimental

Patients in this arm will discuss diabetes medication for glucose control with the help of a decision aid that covers five commonly prescribed anti-hyperglycemic medications.

干预措施: Diabetes Medication Choice decision aid (Behavioral)

Usual Care

Other

Patients and clinicians in this arm will discuss anti-hyperglycemic agents in their usual manner.

干预措施: Usual Care (Behavioral)

结局指标

主要结局

Understanding

时间窗: Directly proceeding the clinical encounter

Decisional Conflict

时间窗: Directly proceeding the clinical visit

Treatment Action, adherence

时间窗: Directly proceeding the clinical encounter, 6 months after the clinical encounter

次要结局

  • Trust(Directly proceeding the clinical visit)
  • Acceptability(Directly proceeding the clinical encounter)

研究者

发起方
Mayo Clinic
申办方类型
Other

研究点 (1)

Loading locations...

相似试验

Diabetes Medication Choice | 临床试验